Concepts (129)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cardiac Catheterization | 8 | 2024 | 630 | 0.970 |
Why?
|
| Heart Defects, Congenital | 8 | 2024 | 1889 | 0.890 |
Why?
|
| Pulmonary Veins | 3 | 2024 | 167 | 0.850 |
Why?
|
| Fontan Procedure | 2 | 2023 | 180 | 0.810 |
Why?
|
| Stenosis, Pulmonary Vein | 2 | 2024 | 23 | 0.780 |
Why?
|
| Stents | 7 | 2024 | 799 | 0.750 |
Why?
|
| Catheterization, Peripheral | 2 | 2019 | 118 | 0.630 |
Why?
|
| Metals | 1 | 2019 | 70 | 0.560 |
Why?
|
| Drug-Eluting Stents | 1 | 2019 | 67 | 0.560 |
Why?
|
| Tissue Plasminogen Activator | 1 | 2018 | 104 | 0.530 |
Why?
|
| Thrombolytic Therapy | 1 | 2018 | 191 | 0.510 |
Why?
|
| Ultrasonography, Interventional | 1 | 2018 | 205 | 0.490 |
Why?
|
| Thrombosis | 2 | 2018 | 499 | 0.480 |
Why?
|
| Angioplasty, Balloon | 3 | 2024 | 122 | 0.470 |
Why?
|
| Hospitals, Pediatric | 1 | 2018 | 808 | 0.390 |
Why?
|
| Endovascular Procedures | 2 | 2024 | 802 | 0.360 |
Why?
|
| Pacemaker, Artificial | 2 | 2010 | 193 | 0.340 |
Why?
|
| Heart Valve Prosthesis | 3 | 2020 | 303 | 0.320 |
Why?
|
| Fibrinolytic Agents | 2 | 2023 | 182 | 0.310 |
Why?
|
| Electrodes, Implanted | 1 | 2010 | 180 | 0.300 |
Why?
|
| Treatment Outcome | 13 | 2024 | 12936 | 0.300 |
Why?
|
| Septal Occluder Device | 2 | 2023 | 53 | 0.270 |
Why?
|
| Retrospective Studies | 13 | 2024 | 17753 | 0.260 |
Why?
|
| Pulmonary Artery | 2 | 2024 | 434 | 0.240 |
Why?
|
| Vascular Closure Devices | 1 | 2024 | 9 | 0.210 |
Why?
|
| Splenic Vein | 1 | 2024 | 10 | 0.210 |
Why?
|
| Hepatic Veins | 1 | 2024 | 20 | 0.210 |
Why?
|
| Arterial Occlusive Diseases | 2 | 2016 | 99 | 0.210 |
Why?
|
| Prosthesis Design | 4 | 2020 | 643 | 0.200 |
Why?
|
| Child | 14 | 2024 | 26341 | 0.200 |
Why?
|
| Pulmonary Circulation | 1 | 2024 | 113 | 0.200 |
Why?
|
| Child, Preschool | 9 | 2024 | 15110 | 0.200 |
Why?
|
| Electrocoagulation | 1 | 2023 | 30 | 0.190 |
Why?
|
| Pulmonary Valve | 2 | 2020 | 83 | 0.180 |
Why?
|
| Catheterization | 2 | 2016 | 226 | 0.180 |
Why?
|
| Heart Septal Defects, Atrial | 1 | 2023 | 138 | 0.180 |
Why?
|
| Hemodynamics | 3 | 2020 | 810 | 0.170 |
Why?
|
| Vascular Patency | 2 | 2019 | 185 | 0.170 |
Why?
|
| Infant | 7 | 2024 | 13352 | 0.160 |
Why?
|
| Venous Thromboembolism | 1 | 2023 | 195 | 0.160 |
Why?
|
| Heart Injuries | 1 | 2020 | 48 | 0.160 |
Why?
|
| Tricuspid Valve | 1 | 2020 | 58 | 0.160 |
Why?
|
| Adipocytes | 1 | 2021 | 178 | 0.150 |
Why?
|
| Tricuspid Valve Insufficiency | 1 | 2020 | 61 | 0.150 |
Why?
|
| Heart Diseases | 1 | 2023 | 499 | 0.140 |
Why?
|
| Glucocorticoids | 1 | 2021 | 348 | 0.140 |
Why?
|
| Upper Extremity | 1 | 2019 | 53 | 0.140 |
Why?
|
| Humans | 21 | 2024 | 131163 | 0.140 |
Why?
|
| Heart | 1 | 2023 | 650 | 0.140 |
Why?
|
| Time Factors | 5 | 2020 | 6196 | 0.140 |
Why?
|
| Ventricular Septum | 1 | 2018 | 16 | 0.140 |
Why?
|
| Pulmonary Atresia | 1 | 2018 | 48 | 0.130 |
Why?
|
| Aortic Valve Insufficiency | 1 | 2019 | 149 | 0.130 |
Why?
|
| Recurrence | 2 | 2019 | 1489 | 0.130 |
Why?
|
| Hypertension, Pulmonary | 1 | 2022 | 457 | 0.130 |
Why?
|
| Transposition of Great Vessels | 1 | 2018 | 118 | 0.130 |
Why?
|
| Male | 14 | 2024 | 64957 | 0.130 |
Why?
|
| Echocardiography | 2 | 2023 | 1125 | 0.130 |
Why?
|
| Transcatheter Aortic Valve Replacement | 1 | 2019 | 228 | 0.120 |
Why?
|
| Adolescent | 8 | 2024 | 20987 | 0.120 |
Why?
|
| Aortic Valve | 1 | 2019 | 455 | 0.120 |
Why?
|
| Young Adult | 5 | 2021 | 10103 | 0.120 |
Why?
|
| Heart Valve Prosthesis Implantation | 1 | 2020 | 425 | 0.120 |
Why?
|
| Infant, Newborn | 5 | 2023 | 8635 | 0.120 |
Why?
|
| Female | 13 | 2024 | 70963 | 0.110 |
Why?
|
| Aortic Valve Stenosis | 1 | 2019 | 350 | 0.110 |
Why?
|
| Acute Disease | 1 | 2018 | 1153 | 0.110 |
Why?
|
| Follow-Up Studies | 3 | 2022 | 5196 | 0.110 |
Why?
|
| Age Factors | 2 | 2019 | 2825 | 0.110 |
Why?
|
| Reoperation | 1 | 2018 | 818 | 0.110 |
Why?
|
| Thrombectomy | 1 | 2016 | 117 | 0.110 |
Why?
|
| Venous Thrombosis | 1 | 2016 | 164 | 0.100 |
Why?
|
| Adult | 7 | 2021 | 31282 | 0.100 |
Why?
|
| Heart Ventricles | 1 | 2018 | 749 | 0.100 |
Why?
|
| Equipment Design | 2 | 2016 | 512 | 0.100 |
Why?
|
| Gene Expression Regulation | 1 | 2021 | 2323 | 0.100 |
Why?
|
| Transcription Factors | 1 | 2021 | 2406 | 0.090 |
Why?
|
| Cardiac Resynchronization Therapy Devices | 1 | 2010 | 17 | 0.080 |
Why?
|
| Aortic Coarctation | 1 | 2011 | 99 | 0.080 |
Why?
|
| Texas | 1 | 2019 | 3686 | 0.080 |
Why?
|
| Risk Factors | 3 | 2020 | 11074 | 0.080 |
Why?
|
| Balloon Valvuloplasty | 2 | 2020 | 27 | 0.070 |
Why?
|
| Obesity | 1 | 2021 | 2426 | 0.070 |
Why?
|
| Feasibility Studies | 2 | 2022 | 824 | 0.070 |
Why?
|
| Arrhythmias, Cardiac | 2 | 2023 | 482 | 0.060 |
Why?
|
| Risk Assessment | 2 | 2020 | 3711 | 0.060 |
Why?
|
| Vascular Surgical Procedures | 1 | 2011 | 534 | 0.060 |
Why?
|
| Postoperative Complications | 1 | 2018 | 3147 | 0.060 |
Why?
|
| Cyanosis | 1 | 2024 | 41 | 0.050 |
Why?
|
| Heparin, Low-Molecular-Weight | 1 | 2023 | 22 | 0.050 |
Why?
|
| Angiography | 1 | 2024 | 179 | 0.050 |
Why?
|
| Vitamin K | 1 | 2023 | 36 | 0.050 |
Why?
|
| Pyridones | 1 | 2023 | 140 | 0.050 |
Why?
|
| Echocardiography, Transesophageal | 1 | 2023 | 246 | 0.040 |
Why?
|
| Magnetic Resonance Imaging, Cine | 1 | 2023 | 176 | 0.040 |
Why?
|
| Constriction, Pathologic | 1 | 2022 | 221 | 0.040 |
Why?
|
| Pyrazoles | 1 | 2023 | 349 | 0.040 |
Why?
|
| Adipose Tissue, Brown | 1 | 2021 | 89 | 0.040 |
Why?
|
| Preoperative Care | 1 | 2023 | 358 | 0.040 |
Why?
|
| Adipogenesis | 1 | 2021 | 82 | 0.040 |
Why?
|
| Gene Silencing | 1 | 2021 | 229 | 0.040 |
Why?
|
| Hemorrhage | 1 | 2023 | 487 | 0.040 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2021 | 526 | 0.040 |
Why?
|
| Anticoagulants | 1 | 2023 | 605 | 0.040 |
Why?
|
| Prosthesis Failure | 1 | 2019 | 159 | 0.040 |
Why?
|
| Fluoroscopy | 1 | 2019 | 108 | 0.040 |
Why?
|
| Radiation Dosage | 1 | 2019 | 132 | 0.030 |
Why?
|
| Operative Time | 1 | 2019 | 201 | 0.030 |
Why?
|
| Decompression, Surgical | 1 | 2018 | 83 | 0.030 |
Why?
|
| Device Removal | 1 | 2019 | 225 | 0.030 |
Why?
|
| Recovery of Function | 1 | 2019 | 449 | 0.030 |
Why?
|
| Middle Aged | 2 | 2021 | 28601 | 0.030 |
Why?
|
| Phlebography | 1 | 2016 | 41 | 0.030 |
Why?
|
| Retreatment | 1 | 2016 | 85 | 0.030 |
Why?
|
| Vascular Access Devices | 1 | 2016 | 31 | 0.030 |
Why?
|
| Angioplasty | 1 | 2016 | 63 | 0.030 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2018 | 1071 | 0.030 |
Why?
|
| Quality of Life | 1 | 2023 | 2082 | 0.020 |
Why?
|
| Logistic Models | 1 | 2018 | 1797 | 0.020 |
Why?
|
| Mice, Knockout | 1 | 2021 | 3819 | 0.020 |
Why?
|
| Length of Stay | 1 | 2019 | 1421 | 0.020 |
Why?
|
| Cross-Sectional Studies | 1 | 2021 | 3829 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 1 | 2021 | 4738 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2023 | 3763 | 0.020 |
Why?
|
| Signal Transduction | 1 | 2021 | 4686 | 0.020 |
Why?
|
| Mice | 1 | 2021 | 18301 | 0.010 |
Why?
|
| Aged | 1 | 2021 | 21025 | 0.010 |
Why?
|
| United States | 1 | 2018 | 12072 | 0.010 |
Why?
|
| Animals | 1 | 2021 | 33912 | 0.010 |
Why?
|